Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ND0612H
ND0612H
NeuroDerm shares up 65 percent on mid-stage results for Parkinson's disease drugs
First Word Pharma
Tue, 12/30/14 - 11:50 am
NeuroDerm
Parkinson's Disease
ND0612H
ND0612L